Lead Product(s) : Undisclosed
Therapeutic Area : Musculoskeletal
Study Phase : Discovery Platform
Sponsor : Eli Lilly
Deal Size : $650.0 million
Deal Type : Collaboration
Eli Lilly Works Out $650M Juvena Pact to Find Muscle-Boosting Drugs
Details : The collaboration aims to discover, develop, and commercialize drug candidates that improve muscle health and body composition.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Undisclosed
June 11, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Musculoskeletal
Highest Development Status : Discovery Platform
Sponsor : Eli Lilly
Deal Size : $650.0 million
Deal Type : Collaboration
Lead Product(s) : Undisclosed
Therapeutic Area : Musculoskeletal
Study Phase : Discovery Platform
Sponsor : SOLVE FSHD
Deal Size : Undisclosed
Deal Type : Collaboration
SOLVE FSHD, Transcripta Collaborate on Drug Discovery for FSHD
Details : The collaboration will focus on leveraging Transcripta Bio’s advanced drug screening platform to identify and develop promising therapeutic candidates for FSHD.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
March 25, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Musculoskeletal
Highest Development Status : Discovery Platform
Sponsor : SOLVE FSHD
Deal Size : Undisclosed
Deal Type : Collaboration